Wound surface tissue and necrotic material

Wound surface tissue and necrotic material, commonly referred to as eschar or slough, represent devitalized biological matter that accumulates in chronic or acute wounds (WoundSource, 2023). This material consists of a complex mixture of denatured extracellular matrix proteins—primarily collagen, fibrin, and elastin—along with dead cells and often a bacterial biofilm (PubMed, 21248458). Its presence is a significant clinical impediment because it provides a medium for bacterial growth, prolongs the inflammatory phase of healing, and acts as a physical barrier to re-epithelialization and the formation of healthy granulation tissue (StatPearls, NBK507882). While not a molecular target in the traditional sense (like a receptor or enzyme), it serves as the pathological substrate for debridement therapies. Enzymatic debriding agents, such as collagenase or bromelain-based products, are designed to interact with this material by proteolytically degrading its structural components, thereby facilitating its removal and promoting a wound environment conducive to physiological repair (NIH, PMC3506163).

Other names

Necrotic tissueEscharSloughDevitalized tissueWound debrisNon-viable tissue

Enzymatic debridement involves the application of exogenous proteolytic enzymes to the wound surface to selectively digest and liquefy necrotic tissue components, such as collagen, fibrin, and elastin, without harming viable granulation tissue (StatPearls, NBK507882).